Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Prostate|February 24, 2025
Translation, Cross-Cultural Adaptation, and Psychometric Validation of the Turkish Version of the "Expanded Prostate Cancer Index Composite (EPIC)" in Prostate Cancer PatientsBurak Tilki, Pervin Hurmuz, Deniz Yuce, et al.
Urologic Oncology|January 11, 2023
Treatment outcomes of postoperative ultra-hypofractionated stereotactic body radiotherapy in prostate cancerGokhan Ozyigit, Cem Onal, Caglayan Selenge Beduk Esen, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 10, 2025
Predicting acute and late toxicity in prostate cancer stereotactic ablative radiotherapy: the role of dosimetric parameters and prostate volumeGokhan Ozyigit, Pervin Hurmuz, Pantea Bayatfard, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2021
Stereotactic radiotherapy to oligoprogressive lesions detected with 68Ga-PSMA-PET/CT in castration-resistant prostate cancer patientsCem Onal, Gokhan Ozyigit, Ezgi Oymak, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 4, 2022
The role of stereotactic body radiotherapy in switching systemic therapy for patients with extracranial oligometastatic renal cell carcinomaCem Onal, Pervin Hurmuz, Ozan Cem Guler, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 30, 2022
Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional studyCem Onal, Ezgi Oymak, Ozan Cem Guler, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 13, 2022
Bone-only oligometastatic renal cell carcinoma patients treated with stereotactic body radiotherapy: a multi-institutional studyCem Onal, Ozan Cem Guler, Pervin Hurmuz, et al.
Urologia Internationalis|December 1, 2022
Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell CarcinomaOzan Cem Guler, Ezgi Oymak, Pervin Hurmuz, et al.
The Prostate|May 5, 2021
Clinical parameters and nomograms for predicting lymph node metastasis detected with 68 Ga-PSMA-PET/CT in prostate cancer patients candidate to definitive radiotherapyCem Onal, Gokhan Ozyigit, Ezgi Oymak, et al.
Clinical and Translational Radiation Oncology|August 9, 2026
Stereotactic body radiotherapy for bone-only oligometastatic bladder Cancer: a multi-institutional experienceBurak Tilki, Ozan Cem Guler, Birhan Demirhan, et al.
Pageof 2